Press Releases from Exactitude Consultancy (19422 total)
Carcinoid Tumor Market Outlook 2025-2034: Expanding Diagnostics and Targeted The …
In 2024, the global carcinoid tumor market is estimated at USD 2.4 billion and is projected to reach USD 5.1 billion by 2034, growing at…
Chronic Myelocytic Leukemia (CML) Market New Product Development & Latest Trends
Introduction
Chronic myelocytic leukemia (CML), also known as chronic myeloid leukemia, is a rare type of blood cancer characterized by the uncontrolled growth of abnormal white…
CAR-T Cell Therapy for Multiple Myeloma Market Outlook 2024-2034: Breakthrough C …
In 2024, the global CAR-T cell therapy for multiple myeloma market is valued at USD 3.1 billion and is projected to reach USD 15.4 billion…
Bruton's Tyrosine Kinase (BTK) Hematological Cancer Market Outlook 2024-2034: Ta …
In 2024, the global BTK hematological cancer market is valued at USD 8.7 billion and is projected to reach USD 21.5 billion by 2034, growing…
BRAF Mutant Metastatic Melanoma Market Outlook 2024-2034: Targeted Therapies and …
In 2024, the global BRAF mutant metastatic melanoma market is estimated at USD 1.6 billion. By 2034, it is projected to reach USD 3.9 billion,…
Basal Cell Neoplasms Market 2025-2034: Early Diagnosis, Minimally Invasive Care, …
In 2024, the Basal Cell Neoplasms market is valued at USD 5.0 billion and is projected to reach USD 9.5 billion by 2034, advancing at…
Chronic Myeloid Leukemia (CML) Market Set to Witness Significant Growth by 2025- …
Introduction
Chronic myeloid leukemia (CML), a rare blood cancer caused by the BCR-ABL gene fusion, has undergone a therapeutic revolution over the last two decades. Once…
NK Cell Therapy Market Outlook 2024-2034: Revolutionizing Cancer Immunotherapy
In 2024, the global NK cell therapy market is estimated at USD 2.1 billion. By 2034, it is projected to reach USD 12.8 billion, growing…
Neuroendocrine Tumors Market Outlook 2024-2034, Targeted Therapies Driving Stron …
In 2024, the global neuroendocrine tumors (NETs) market is valued at USD 4.6 billion. It is projected to reach USD 9.5 billion by 2034, growing…
Cell Ovarian Cancer Market 2025-2034 Business Outlook, Critical Insight and Grow …
Introduction
Clear cell ovarian cancer (CCOC) is a molecularly distinct subtype of epithelial ovarian cancer with unique clinical behavior, therapy responses, and biomarker patterns. Though it…
Germ Cell Tumor Market Outlook 2024-2034: Innovation Driving Steady Growth
The global germ cell tumor market is evolving with major pharmaceutical companies, healthcare providers, and research institutions focusing on improved detection, tailored therapies, and survivorship…
Cutaneous Angiosarcoma Market New Product Development & Latest Trends
Introduction
Cutaneous angiosarcoma is a rare and aggressive malignancy that originates from endothelial cells lining blood vessels and lymphatics in the skin. Though it represents a…
Indolent Lymphoma Market to Reach USD 17.2 Billion by 2034
Indolent lymphomas are a group of slow-growing non-Hodgkin's lymphomas (NHL) that include follicular lymphoma, marginal zone lymphoma, small lymphocytic lymphoma, and lymphoplasmacytic lymphoma. While generally…
HPV-Induced Cutaneous Tumors Market is expected to reach USD 2.5 billion by 2034
Human papillomavirus (HPV) is widely known for its role in cervical and other anogenital cancers, but it also causes a spectrum of cutaneous tumors, ranging…
Higher-Risk Chronic Myelomonocytic Leukemia Market is expected to reach USD 2.5 …
Chronic myelomonocytic leukemia (CMML) is a rare hematologic malignancy with overlapping features of myelodysplastic syndromes (MDS) and myeloproliferative neoplasms (MPNs). Patients with higher-risk CMML face…
Ependymoma Market Emerging Trends and Growth Prospects 2034
Introduction
Ependymoma is a rare type of tumor arising from the ependymal cells of the central nervous system, often occurring in the brain or spinal cord.…
HER2-Positive Early Breast Cancer Market is expected to reach USD 13.5 billion b …
Breast cancer remains the most common cancer among women worldwide, with HER2-positive tumors representing around 15-20% of all breast cancer cases. These tumors are characterized…
HER2+ Non-Small Cell Lung Cancer Market is expected to reach USD 12.3 billion by …
Non-small cell lung cancer (NSCLC) accounts for nearly 85% of all lung cancers, and among its subtypes, HER2-mutant NSCLC is an important focus of research…
Hepatocellular Carcinoma Market is expected to reach USD 4.8 billion by 2034
Hepatocellular carcinoma (HCC) is the most common type of primary liver cancer, accounting for nearly 90% of all liver malignancies worldwide. It is strongly linked…
Gliosarcoma Market is expected to reach USD 1.1 billion by 2034
Gliosarcoma is a rare and highly aggressive variant of glioblastoma, classified as a grade IV malignant brain tumor. It combines both glial and sarcomatous components,…
Gastric Neuroendocrine Tumors Market to Reach USD 4.5 Billion by 2034.
Gastric neuroendocrine tumors (G-NETs) are rare tumors that originate from neuroendocrine cells in the stomach. Although accounting for a small percentage of gastrointestinal malignancies, their…
Gallbladder Cancer Market is expected to reach USD 2.1 billion by 2034
Gallbladder cancer (GBC) is a rare but aggressive malignancy of the biliary tract, often diagnosed at advanced stages due to vague symptoms and limited early…
Eye Neoplasms Market is expected to reach USD 4.1 billion by 2034
Eye neoplasms, which include both benign and malignant tumors affecting the eye and surrounding tissues, are rare but potentially vision- and life-threatening conditions. They include…
Erdheim-Chester Disease Market is expected to reach USD 3 billion by 2034
Erdheim-Chester Disease (ECD) is an extremely rare form of non-Langerhans cell histiocytosis that affects multiple organ systems, including the bones, cardiovascular system, and central nervous…
Epithelioid Sarcoma Market is expected to reach USD 1.2 billion by 2034
Epithelioid sarcoma is a rare and aggressive form of soft tissue sarcoma that typically affects young adults and adolescents. Despite being classified as a soft…
Desmoplastic Small Round Cell Tumors Market is expected to reach USD 2.5 billion …
Desmoplastic small round cell tumors (DSRCTs) are an extremely rare and aggressive form of soft tissue sarcoma, primarily affecting adolescents and young adults. Classified as…
Craniopharyngioma Market is expected to reach USD 1.2 billion by 2034
Craniopharyngioma is a rare, benign but aggressive brain tumor that develops near the pituitary gland. While not malignant, it can cause significant health issues due…
Chronic Phase Chronic Myeloid Leukemia Market is expected to reach USD 18 billio …
Chronic myeloid leukemia (CML) is a rare hematological cancer that progresses through different phases-chronic, accelerated, and blast crisis. Among these, the chronic phase is the…
Chronic Myelogenous Leukemia Market is expected to double, reaching USD 15 billi …
Chronic myelogenous leukemia (CML) is a rare but serious blood cancer that has witnessed a dramatic transformation in treatment outcomes over the past two decades.…
Chemotherapy-Induced Pain Market is expected to reach USD 7.2 billion by 2034
Cancer treatment has advanced rapidly in recent decades, but chemotherapy-the backbone of systemic cancer therapy-continues to bring severe side effects. One of the most debilitating…
Chemotherapy-Induced Anemia Market is expected to reach USD 7.2 billion by 2034
Chemotherapy remains one of the most common and effective treatments for cancer, but it often comes with significant side effects. Among these, chemotherapy-induced anemia (CIA)…
ER+/HER2- Breast Cancer Market Insights and Future Outlook
Introduction
Estrogen receptor-positive, HER2-negative (ER+/HER2-) breast cancer is the most common molecular subtype of breast cancer, accounting for nearly 70% of all breast cancer diagnoses worldwide.…
Ulcerative Colitis Market Set Phenomenal Growth From 2025 to 2034
Introduction
Ulcerative Colitis (UC) is a chronic inflammatory bowel disease (IBD) characterized by inflammation of the colon , resulting in abdominal pain, diarrhea, rectal bleeding, fatigue,…
Cervical Intraepithelial Neoplasia Market is expected to reach USD 3.3 billion b …
Cervical cancer is one of the leading causes of cancer-related deaths among women worldwide. However, its development can often be prevented through early detection and…
Castrate-Resistant Prostate Cancer Market to Exceed USD 30.1 Billion by 2034
Prostate cancer is one of the most prevalent cancers among men worldwide. While androgen deprivation therapy (ADT) remains the standard first-line treatment, many patients eventually…
Barrett's Esophagus Market Barrett's Esophagus Market New Product Development & …
Introduction
Barrett's Esophagus is a precancerous condition in which the lining of the esophagus is replaced by intestinal-type cells due to chronic acid reflux (GERD). While…
Gallbladder Neoplasms Market Emerging Trends and Growth Prospects 2034
Introduction
Gallbladder neoplasms are rare but aggressive malignancies arising in the biliary tract, most often diagnosed at advanced stages due to their asymptomatic progression. With high…
Carcinoid Syndrome Market is expected to reach USD 3.5 billion by 2034
Carcinoid syndrome is a rare but serious condition that develops when neuroendocrine tumors (NETs) produce excess hormones such as serotonin. Patients often experience flushing, diarrhea,…
Gallbladder Neoplasms Market Emerging Trends and Growth Prospects 2034
Introduction
Gallbladder neoplasms are rare but aggressive malignancies arising in the biliary tract, most often diagnosed at advanced stages due to their asymptomatic progression. With high…
Cancer Anorexia Cachexia Syndrome Market is expected to reach USD 3.5 billion by …
Cancer treatment has made tremendous progress in recent decades, yet certain complications remain major challenges for patients and clinicians alike. Cancer Anorexia Cachexia Syndrome (CACS)…
Gene Therapies for Cardiomyopathies Market Detailed Industry Report Analysis 202 …
Introduction
Cardiomyopathies are a group of diseases that affect the heart muscle, leading to impaired cardiac function and, in severe cases, heart failure or sudden cardiac…
Breast cancer biomarker market to reach USD 38.6 billion by 2034
Breast cancer remains the most common malignancy among women worldwide, with millions of new cases reported each year. Early detection, accurate diagnosis, and targeted treatment…
Bowen's Disease Market is expected to reach USD 445 million by 2034
Bowen's disease, also known as squamous cell carcinoma in situ, is an early form of skin cancer that appears as persistent, scaly red patches. While…
Radiation-Induced Oral Mucositis in Head and Neck Cancer Market is expected to r …
Head and neck cancers (HNC) are among the most challenging malignancies, requiring complex treatment regimens that often involve high-dose radiation therapy. While effective in targeting…
HER2+ Metastatic Non-Small Cell Lung Cancer Market Detailed Industry Report Anal …
Introduction
Non-small cell lung cancer (NSCLC) accounts for nearly 85% of all lung cancer diagnoses and is characterized by significant molecular heterogeneity. Among the various subtypes,…
HER2-Negative Breast Cancer Market Detailed Industry Report Analysis 2025-2034
Introduction
Breast cancer is the most common cancer among women worldwide, but not all tumors are the same. Approximately 70% of all breast cancers are classified…
HER2-Negative Metastatic Breast Cancer Market Massive Growth opportunity Ahead
Introduction
Breast cancer remains the most common cancer in women worldwide, but not all forms behave the same way. HER2-negative metastatic breast cancer (MBC)-a subtype that…
Gastric Cancer Market Massive Growth opportunity Ahead
Introduction
Gastric cancer, also known as stomach cancer, remains one of the leading causes of cancer-related mortality worldwide. It typically originates in the lining of the…
Chronic Myelomonocytic Leukemia (CMML) Market Growth, Applications, Innovations …
Introduction
Chronic Myelomonocytic Leukemia (CMML) is a rare hematologic malignancy characterized by features of both myelodysplastic syndromes (MDS) and myeloproliferative neoplasms (MPNs). It is defined by…
Diffuse Large B-Cell Lymphoma (DLBCL) Market Growth, Trends, Consumer Demand and …
Introduction
Diffuse Large B-Cell Lymphoma (DLBCL) is the most common subtype of non-Hodgkin lymphoma (NHL), accounting for approximately 30-40% of cases globally. It is an aggressive…
Go To Page: 31 32 33 34 35 36 37 38 39 40 311 312 313 314 315 316 317 318 319 320
